Insider Transactions in Q3 2021 at Oscar Health, Inc. (OSCR)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 16
2021
|
Mario Schlosser President of Technology & CTO |
BUY
Open market or private purchase
|
Direct |
57,300
+49.99%
|
$974,100
$17.53 P/Share
|
Sep 15
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
323,725
+6.37%
|
$5,503,325
$17.86 P/Share
|
Sep 15
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
323,725
+6.37%
|
$5,503,325
$17.86 P/Share
|
Sep 14
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
515,344
+10.42%
|
$9,276,192
$18.1 P/Share
|
Sep 14
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
515,344
+10.42%
|
$9,276,192
$18.1 P/Share
|
Sep 13
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
377,552
+4.7%
|
$6,418,384
$17.18 P/Share
|
Sep 13
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
377,552
+4.7%
|
$6,418,384
$17.18 P/Share
|
Sep 10
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
250,000
+6.6%
|
$4,250,000
$17.5 P/Share
|
Sep 10
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
250,000
+6.6%
|
$4,250,000
$17.5 P/Share
|
Sep 09
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
444,712
+6.53%
|
$7,560,104
$17.46 P/Share
|
Sep 09
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
444,712
+6.53%
|
$7,560,104
$17.46 P/Share
|
Sep 03
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
157,135
+5.24%
|
$2,828,430
$18.35 P/Share
|
Sep 03
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
157,135
+5.24%
|
$2,828,430
$18.35 P/Share
|
Sep 02
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
328,351
+5.93%
|
$5,581,967
$17.94 P/Share
|
Sep 02
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
328,351
+5.93%
|
$5,581,967
$17.94 P/Share
|
Sep 01
2021
|
Dennis Weaver Chief Clinical Officer |
SELL
Open market or private sale
|
Direct |
3,027
-36.25%
|
$51,459
$17.21 P/Share
|
Sep 01
2021
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+49.95%
|
-
|
Sep 01
2021
|
Meghan V. Joyce Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
24,014
-40.92%
|
$408,238
$17.17 P/Share
|
Sep 01
2021
|
Meghan V. Joyce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,666
+49.99%
|
-
|
Aug 31
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
305,539
+6.21%
|
$4,583,085
$15.12 P/Share
|
Aug 31
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
305,539
+6.21%
|
$4,583,085
$15.12 P/Share
|
Aug 30
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
329,885
+7.35%
|
$4,618,390
$14.98 P/Share
|
Aug 30
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
329,885
+7.35%
|
$4,618,390
$14.98 P/Share
|
Aug 27
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
217,590
+11.21%
|
$3,046,260
$14.05 P/Share
|
Aug 27
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
217,590
+11.21%
|
$3,046,260
$14.05 P/Share
|
Aug 26
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
204,811
+11.98%
|
$2,662,543
$13.74 P/Share
|
Aug 26
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
204,811
+11.98%
|
$2,662,543
$13.74 P/Share
|
Aug 25
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
31,794
+2.39%
|
$413,322
$13.18 P/Share
|
Aug 25
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
31,794
+2.39%
|
$413,322
$13.18 P/Share
|
Aug 24
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
1,074,342
+45.85%
|
$12,892,104
$12.69 P/Share
|
Aug 24
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
1,074,342
+45.85%
|
$12,892,104
$12.69 P/Share
|
Aug 23
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
125,900
+39.3%
|
$1,636,700
$13.01 P/Share
|
Aug 23
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
125,900
+39.3%
|
$1,636,700
$13.01 P/Share
|
Aug 20
2021
|
Thrive Partners Vii Growth Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
68,042
+49.82%
|
$884,546
$13.41 P/Share
|
Aug 20
2021
|
Joshua Kushner Co-Founder and Vice Chairman |
BUY
Open market or private purchase
|
Indirect |
68,542
+50.0%
|
$891,046
$13.41 P/Share
|
Aug 18
2021
|
Meghan V. Joyce Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
Aug 18
2021
|
Mario Schlosser President of Technology & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
Aug 18
2021
|
Joel Klein Chief Policy & Strat. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|
Aug 18
2021
|
Dennis Weaver Chief Clinical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17
+50.0%
|
-
|